Fatty Liver Disease - Pipeline Review, H2 2012 New Report
Fatty Liver Disease - Pipeline Review, H2 2012, provides an overview of the Fatty Liver Disease therapeutic pipeline. This report provides information on the therapeutic development for Fatty Liver Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fatty Liver Disease. 'Fatty Liver Disease - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release